Zum Inhalt springen Zur Suche springen

News-Detail

Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Kirsten I Taylor et al., NPJ Digit Med. 2025

Kirsten I Taylor, Florian Lipsmeier, Marzia A Scelsi, Ekaterina Volkova-Volkmar, Daria Rukina, Werner Popp, Stefan Lambrecht, Judith Anzures-Cabrera, David Summers, Markus Abt, Annabelle Monnet, Timothy Kilchenmann, Jens Schjodt-Eriksen, Laurent Essioux, Thomas Kustermann, Wagner Zago, Hanno Svoboda, Tania Nikolcheva, Ronald B Postuma, Gennaro Pagano, Michael Lindemann; PASADENA Investigators; Prasinezumab Study Group.

Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.

NPJ Digit Med. 2025 Jun 16;8(1):365. doi: 10.1038/s41746-025-01572-8. PubMed ID: 40523921

 

Further Information:

DOI: 10.1038/s41746-025-01572-8

Alfons Schnitzler

Kategorie/n: NND-Publikationen